Artificial intelligence in assessment of hepatocellular carcinoma treatment response.
Publication
, Journal Article
Spieler, B; Sabottke, C; Moawad, AW; Gabr, AM; Bashir, MR; Do, RKG; Yaghmai, V; Rozenberg, R; Gerena, M; Yacoub, J; Elsayes, KM
Published in: Abdom Radiol (NY)
August 2021
Artificial Intelligence (AI) continues to shape the practice of radiology, with imaging of hepatocellular carcinoma (HCC) being of no exception. This article prepared by members of the LI-RADS Treatment Response (TR LI-RADS) work group and associates, presents recent trends in the utility of AI applications for the volumetric evaluation and assessment of HCC treatment response. Various topics including radiomics, prognostic imaging findings, and locoregional therapy (LRT) specific issues will be discussed in the framework of HCC treatment response classification systems with focus on the Liver Reporting and Data System treatment response algorithm (LI-RADS TRA).
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Abdom Radiol (NY)
DOI
EISSN
2366-0058
Publication Date
August 2021
Volume
46
Issue
8
Start / End Page
3660 / 3671
Location
United States
Related Subject Headings
- Retrospective Studies
- Magnetic Resonance Imaging
- Liver Neoplasms
- Liver
- Humans
- Carcinoma, Hepatocellular
- Artificial Intelligence
Citation
APA
Chicago
ICMJE
MLA
NLM
Spieler, B., Sabottke, C., Moawad, A. W., Gabr, A. M., Bashir, M. R., Do, R. K. G., … Elsayes, K. M. (2021). Artificial intelligence in assessment of hepatocellular carcinoma treatment response. Abdom Radiol (NY), 46(8), 3660–3671. https://doi.org/10.1007/s00261-021-03056-1
Spieler, Bradley, Carl Sabottke, Ahmed W. Moawad, Ahmed M. Gabr, Mustafa R. Bashir, Richard Kinh Gian Do, Vahid Yaghmai, et al. “Artificial intelligence in assessment of hepatocellular carcinoma treatment response.” Abdom Radiol (NY) 46, no. 8 (August 2021): 3660–71. https://doi.org/10.1007/s00261-021-03056-1.
Spieler B, Sabottke C, Moawad AW, Gabr AM, Bashir MR, Do RKG, et al. Artificial intelligence in assessment of hepatocellular carcinoma treatment response. Abdom Radiol (NY). 2021 Aug;46(8):3660–71.
Spieler, Bradley, et al. “Artificial intelligence in assessment of hepatocellular carcinoma treatment response.” Abdom Radiol (NY), vol. 46, no. 8, Aug. 2021, pp. 3660–71. Pubmed, doi:10.1007/s00261-021-03056-1.
Spieler B, Sabottke C, Moawad AW, Gabr AM, Bashir MR, Do RKG, Yaghmai V, Rozenberg R, Gerena M, Yacoub J, Elsayes KM. Artificial intelligence in assessment of hepatocellular carcinoma treatment response. Abdom Radiol (NY). 2021 Aug;46(8):3660–3671.
Published In
Abdom Radiol (NY)
DOI
EISSN
2366-0058
Publication Date
August 2021
Volume
46
Issue
8
Start / End Page
3660 / 3671
Location
United States
Related Subject Headings
- Retrospective Studies
- Magnetic Resonance Imaging
- Liver Neoplasms
- Liver
- Humans
- Carcinoma, Hepatocellular
- Artificial Intelligence